Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21(Cip1)

Molecular and Cellular Biology

Volumn 17, Issue 9, 1997, Pages 5598-5611

  Woods, Douglas ^a   Parry, David ^a   Cherwinski, Holly ^a   Bosch, Elizabeth ^a   Lees, Emma ^a   McMahon, Martin ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN KINASE; PROTEIN P21; RAF PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; MOUSE; NONHUMAN; ONCOGENE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FAMILY; SACCHAROMYCES CEREVISIAE;

ANIMALIA; MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 0030835430     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.9.5598     Document Type: Article

References (117)

1. Albanese, C., J. Johnson, G. Watanabe, N. Eklund, D. Vu, A. Arnold, and R. G. Pestell. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
2. Alberola-Ila, J., K. A. Forbush, R. Seger, E. G. Krebs, and R. M. Perlmutter. 1995. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature 373:620-623.
3. Ambrosio, L., A. P. Mahowald, and N. Perrimon. 1989. Requirement of the Drosophila raf homologue for torso function. Nature 342:288-291.
4. Avruch, J., X. F. Zhang, and J. M. Kyriakis. 1994. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci. 19:279-283.
5. Aziz, N., H. Cherwinski, and M. McMahon. Unpublished data.
6. Bailleul, B., M. A. Surani, S. White, S. C. Barton, K. Brown, M. Blessing, J. Jorcano, and A. Balmain. 1990. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell 62:697-708.
7. Bos, J. L. 1989. Ras oncogenes in human cancer: a review. Cancer Res. 49:4682-4689.
8. Bosch, E., H. Cherwinski, D. Peterson, and M. McMahon. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1. Oncogene, in press.
9. Buscher, D., P. Dello Sparba, R. A. Hipskind, U. R. Rapp, E. R. Stanley, and M. Baccarini. 1993. v-raf confers CSF-1 independent growth to a macrophage cell line and leads to immediate early gene expression without MAP-kinase activation. Oncogene 8:3323-3332.
10. Chen, D., D. Woods, and M. McMahon. Unpublished data.
11. Chin, Y. E., M. Kitagawa, W. C. Su, Z. H. You, Y. Iwamoto, and X. Y. Fu. 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272:719-722.
12. Cleveland, J. L., J. Troppmair, G. Packham, D. S. Askew, P. Lloyd, G. M. Gonzalez, G. Nunez, J. N. Ihle, and U. R. Rapp. 1994. v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. Oncogene 9:2217-2226.
13. Cormack, B. P., R. H. Valdivia, and S. Falkow. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33-38.
14. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
15. Danielian, P. S., R. White, S. A. Hoare, S. E. Fawell, and M. G. Parker. 1993. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol. Endocrinol. 7:232-240.
16. 1 checkpoint control. Cell 82:675-684.
17. de Nooij, J. C., M. A. Letendre, and I. K. Hariharan. 1996. A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis. Cell 87:1237-1247.
18. Dent, P., W. Haser, T. A. J. Haystead, L. A. Vincent, T. M. Roberts, and T. W. Sturgill. 1992. Activation of mitogen-activated protein kinase by v-raf in NIH 3T3 cells and in vitro. Science 257:1404-1407.
19. Dickson, B., and E. Hafen. 1994. Genetics of signal transduction in invertebrates. Curr. Opin. Genet. Dev. 4:64-70.
20. Dickson, B., F. Sprenger, D. Morrison, and E. Hafen. 1992. Raf functions downstream of Ras1 in the Sevenless signal transduction pathway. Nature 360:600-602.
21. Dickson, B. J., M. Dominguez, A. van der Stratten, and E. Hafen. 1995. Control of Drosophila photoreceptor cell fates by phyllopod, a novel nuclear protein acting downstream of the Raf kinase. Cell 80:453-462.
22. Doyle, H. J., and J. M. Bishop. 1993. Torso, a receptor tyrosine kinase required for embryonic pattern formation, shares substrates with the sevenless and EGF-R pathways in Drosophila. Genes Dev. 7:633-646.
23. Egan, S. E., and R. A. Weinberg. 1993. The pathway to signal achievement. Nature 365:781-783.
24. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
25. Fabian, J. R., I. O. Daar, and D. K. Morrison. 1993. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol. Cell. Biol. 13:7170-7179.
26. Fan, Z., Y. Lu, X. Wu, A. DeBlasio, A. Koff, and J. Mendelsohn. 1995. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J. Cell. Biol. 131:235-242.
27. Fang, F., G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti. 1996. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271:499-502.
28. Fero, M. L., M. Rivkin, M. Tasch, P. Porter, C. E. Carow, E. Firpo, K. Polyak, L. H. Tsai, V. Broudy, R. M. Perlmutter, K. Kaushansky, and J. M. Roberts. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733-744.
29. Finney, R. E., S. M. Robbins, and J. M. Bishop. 1993. Association of pRas and pRaf-1 in a complex correlates with activation of a signal transduction pathway. Curr. Biol. 3:805-812.
30. Han, M., A. Golden, Y. Han, and P. W. Sternberg. 1993. C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation. Nature 363:133-139.
31. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
32. 1 cyclin-dependent kinases. Cell 75:805-816.
33. Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, N. P. Fox, and N. Wei. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387-400.
34. Herskowitz, I. 1995. MAP kinase pathways in yeast: for mating and more. Cell 80:187-197.
35. Hill, C. S., R. Marais, S. John, J. Wynne, S. Dalton, and R. Treisman. 1993. Functional analysis of a growth factor-responsive transcription factor complex. Cell 73:395-406.
36. Hill, C. S., and R. Treisman. 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199-211.
37. Howe, L. R., S. J. Leevers, N. Gomez, S. Nakielny, P. Cohen, and C. J. Marshall. 1992. Activation of the MAP kinase pathway by the protein kinase raf. Cell 71:335-342.
38. Hunter, T. 1991. Cooperation between oncogenes. Cell 64:249-270.
39. Hunter, T. 1997. Oncoprotein networks. Cell 88:333-346.
40. Hunter, T., and J. Pines. 1991. Cyclins and cancer. Cell 66:1071-1074.
41. Karin, M. 1994. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr. Opin. Cell Biol. 6:415-424.
42. Kolch, W., G. Heidecker, P. Lloyd, and U. R. Rapp. 1991. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 349:426-428.
43. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Cellular oncogenes and multistep carcinogenesis. Science 222:771-778.
44. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596-602.
45. Lane, M. E., K. Sauer, K. Wallace, Y. N. Jan, C. F. Lehner, and H. Vaessin. 1996. Dacapo, a cyclin-dependent kinase inhibitor, stops cell proliferation during Drosophila development. Cell 87:1225-1235.
46. Lavoie, J. N., G. L'Allemain, A. Brunet, R. Muller, and J. Pouyssegur. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608-20616.
47. Lees, E. 1995. Cyclin dependent kinase regulation. Curr. Biol. 7:773-780.
48. Li, P., K. Wood, H. Mamon, W. Haser, and T. Roberts. 1991. Raf-1: a kinase currently without a cause but not lacking in effects. Cell 64:479-482.
49. Linardopoulos, S., A. J. Street, D. E. Quelle, D. Parry, G. Peters, C. J. Sherr, and A. Balmain. 1995. Deletion and altered regulation of p161NK4a and p15INK4b in undifferentiated mouse skin tumors. Cancer Res. 55: 5168-5172.
50. Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, and G. I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
51. Lloyd, A. C., F. Obermüller, S. Staddon, C. Barth, M. McMahon, and H. Land. 1997. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11:663-677.
52. MacNicol, A. M., A. J. Muslin, and L. T. Williams. 1993. Raf-1 kinase is essential for early Xenopus development and mediates the induction of mesoderm by FGF. Cell 73:571-583.
53. Mangues, R., I. Seidman, A. Pellicer, and J. W. Gordon. 1990. Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene. Oncogene 5:1491-1497.
54. Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, W. G. Vande, and N. G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966-970.
55. Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-394.
56. Marais, R., Y. Light, H. Paterson, and C. J. Marshall. 1995. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14:101-110.
57. Marshall, C. J. 1994. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 4:82-89.
58. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
59. McCarthy, S. A., D. Chen, B.-S. Yang, J. J. Garcia Ramirez, H. Cherwinski, X.-R. Chen, M. Klagsbrun, C. A. Hauser, M. C. Ostrowski, and M. McMahon. 1997. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17:2401-2412.
60. McCarthy, S. A., M. L. Samuels, C. A. Pritchard, J. A. Abraham, and M. McMahon. 1995. Rapid induction of heparin binding epidermal growth factor/diphtheria toxin receptor by Ras and Raf oncogenes. Genes Dev. 9:1953-1964.
61. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077-2086.
62. Miao, G. G., and T. Curran. 1994. Cell transformation by c-fos requires an extended period and is independent of the cell cycle. Mol. Cell. Biol. 14:4295-4310.
63. Missero, C., F. Di Cunto, H. Kiyokawa, A. Koff, and G. P. Dotto. 1996. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev. 10:3065-3075.
64. Mittnacht, S., H. Paterson, M. F. Olson, and C. J. Marshall. 1997. Ras signaling is required for inactivation of the tumor suppressor pRb cell-cycle control protein. Curr. Biol. 7:219-221.
65. Morgan, D. O. 1992. Cell cycle control in normal and neoplastic cells. Curr. Opin. Genet. Dev. 2:33-37.
66. Morgan, D. O. 1995. Principles of cdk regulation. Nature 374:131-134.
67. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
68. Morrison, D. K. 1990. The Raf-1 kinase as a transducer of mitogenic signals. Cancer Cells 2:377-382.
69. Nishida, E., and Y. Gotoh. 1993. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 18:128-131.
70. Nishida, Y., M. Hata, T. Ayaki, H. Ryo, M. Yamagata, K. Shimizu, and Y. Nishizuka. 1988. Proliferation of both somatic and germ cells is affected in the Drosophila mutants of raf proto-oncogene. EMBO J. 7:775-781.
71. Parker, S. B., G. Eichele, P. Zhang, A. Rawls, A. T. Sands, A. Bradley, E. N. Olson, J. W. Harper, and S. J. Elledge. 1995. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267:1024-1027.
72. Parry, D., and E. Lees. Unpublished data.
73. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
74. Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. DeCaprio, and M. E. Ewen. 1997. Ras signaling linked to the cell cycle machinery by the retinoblastoma protein. Nature 386:177-181.
75. Perrimon, N., and L. A. Perkins. 1997. There must be 50 ways to rule the signal: the case of the Drosophila EGF receptor. Cell 89:13-16.
76. Peter M., A. Gartner, J. Horecka, G. Ammerer, and I. Herskowitz. 1993. FAR1 links the signal transduction pathway to the cell cycle machinery in yeast. Cell 73:747-760.
77. 1 and S phase checkpoints. Oncogene 12:1387-1396.
78. Polyak, K., J.-Y. Kato, M. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22.
79. Prasher, D. C., V. K. Eckenrode, W. W. Ward, F. G. Prendergast, and M. J. Cormier. 1992. Primary structure of the Aequorea victoria green-fluorescent protein. Gene 111:229-233.
80. Pritchard, C. A., L. Bolin, R. Slattery, R. L. Murray, and M. McMahon. 1996. Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase. Curr. Biol. 6:614-617.
81. Pritchard, C. A., M. L. Samuels, E. Bosch, and M. McMahon. 1995. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol. Cell. Biol. 15:6430-6442.
82. Pumiglia, K. M., and S. J. Decker. 1997. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA 94:448-452.
83. Quaife, C. J., C. A. Pinkert, D. M. Ornitz, R. D. Palmiter, and R. L. Brinster. 1987. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 48:1023-1034.
84. Quelle, D. E., R. A. Ashmun, G. J. Hannon, P. A. Rehberger, D. Trono, K. H. Richter, C. Walker, D. Beach, C. J. Sherr, and M. Serrano. 1995. Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene 11:635-645.
85. Rapp, U. R. 1991. Role of Raf-1 serine/threonine protein kinase in growth factor signal transduction. Oncogene 6:495-500.
86. Ravi et al. Submitted for publication.
87. Ridley, A. J., H. F. Paterson, M. Noble, and H. Land. 1988. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J. 7:1635-1645.
88. Roussel, M. F., S. A. Shurtleff, J. R. Downing, and C. J. Sherr. 1990. A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes. Proc Natl Acad. Sci. USA 87:6738-6742.
89. Russo, A. A., P. D. Jeffrey, A. K. Patten, J. Massague, and N. P. Pavletich. 1996. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382:325-331.
90. Samuels, M. L., and M. McMahon. 1994. Inhibition of platelet-derived growth factor-and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing ΔRaf-1:ER, an estradiol-regulated form of Raf-1. Mol. Cell. Biol. 14:7855-7866.
91. Samuels, M. L., M. J. Weber, J. M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase. Mol. Cell. Biol. 13:6241-6252.
92. Sandgren, E. P., C. J. Quaife, C. A. Pinkert, R. D. Palmiter, and R. L. Brinster. 1989. Oncogene-induced liver neoplasia in transgenic mice. Oncogene 4:715-724.
93. Serrano, M., H. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R. A. DePinho. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-37.
94. INK4a. Cell 88:593-602.
95. Cip1. Mol. Cell. Biol. 17:5588-5597.
96. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
97. 1 cyclins. Cell 73:1059-1065.
98. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
99. Smith, M. R., S. J. DeGudicibus, and D. W. Stacey. 1986. Requirement for c-ras proteins during viral oncogene transformation. Nature 320:540-543.
100. Smith, M. R., G. Heidecker, U. R. Rapp, and H.-F. Kung. 1990. Induction of transformation and DNA synthesis after microinjection of raf proteins. Mol. Cell. Biol. 10:3828-3833.
101. Sprenger, F., M. M. Trosclair, and D. K. Morrison. 1993. Biochemical analysis of torso and D-Raf during Drosophila embryogenesis: implications for terminal signal transduction. Mol. Cell. Biol. 13:1163-1172.
102. Stanton, V. P., Jr., D. W. Nichols, A. P. Laudano, and G. M. Cooper. 1989. Definition of the human raf amino-terminal regulatory region by deletion mutagenesis. Mol. Cell. Biol. 9:639-647.
103. Steinman, R. A., B. Hoffman, A. Iro, C. Guillouf, D. A. Liebermann, and M. E. el-Houseini. 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389-3396.
104. Sternberg, P. W., A. Golden, and M. Han. 1993. Role of a rat proto-oncogene during Caenorhabditis elegans vulval development. Phil. Trans. R. Soc. Lond. B 340:259-265.
105. Storm, S. M., J. L. Cleveland, and U. R. Rapp. 1990. Expression of raf family proto-oncogenes in normal mouse tissues. Oncogene 5:345-351.
106. Takagi, S., M. L. McFadden, R. E. Humphreys, B. A. Woda, and T. Sairenji. 1993. Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment. Cytometry 14:640-648.
107. Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:205-215.
108. Van Aelst, L., M. Barr, S. Marcus, A. Polverino, and M. Wigler. 1993. Complex formation between RAS and RAF and other protein kinases. Proc. Natl. Acad. Sci. USA 90:6213-6217.
109. Vojtek, A. B., S. M. Hollenberg, and J. A. Cooper. 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74:205-214.
110. Warne, P. H., P. R. Viciana, and J. Downward. 1993. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364:352-355.
111. Winston, J. T., S. R. Coats, Y. Z. Wang, and W. J. Pledger. 1996. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12:127-134.
112. Wood, K. W., H. Qi, G. D'Arcangelo, R. C. Armstrong, T. M. Roberts, and S. Halegoua. 1993. The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction. Proc. Natl. Acad. Sci. USA 90:5016-5020.
113. Woods, D., N. Davidson, and M. McMahon. Unpublished data.
114. Woods, D., H. Cherwinski, and M. McMahon. Unpublished data.
115. Woods, D., N. Aziz, H. Cherwinski, and M. McMahon. Unpublished data.
116. Woods, D., and M. McMahon. Unpublished data.
117. Zhu, X., M. Ohtsubo, R. M. Bohmer, J. M. Roberts, and R. K. Assoian. 1996. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133:391-403.